MedTrace Logo

Assessment of Dried Blood Spot Thyroglobulin and Urinary Iodine Concentration in Pregnant Women

NCT03176706 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2900

Last updated 2020-05-13

No results posted yet for this study

Summary

To avoid iodine deficiency and its consequences in pregnant women and their offspring, women should reach a sufficient iodine intake long before conception. To monitor iodine status, median urinary iodine concentration (UIC) is widely used in pregnant women (PW). Thyroglobulin (Tg) us another marker used to assess iodine status . In this study, urine samples as well as dried blood spots will be collected to measure UIC and Tg (as well as other hormones to define thyroid function) in PW. The results shall be used to reassess the threshold which defines iodine status in PW according to UIC.

Conditions

  • Iodine Deficiency
  • Pregnancy Related

Interventions

OTHER

no intervention

this is a completely observational study, NO INTERVENTION

Sponsors & Collaborators

  • Swiss Federal Institute of Technology

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-09
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03176706 on ClinicalTrials.gov